Overview

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

Status:
Not yet recruiting
Trial end date:
2024-11-08
Target enrollment:
Participant gender:
Summary
This is a study to learn if the experimental medicine (called PF-07054894) is safe, effective, and how it is processed in adult people with ulcers in the colon.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer